Compare MakeMyTrip Ltd (MMYT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs Regeneron Pharmaceuticals Inc — how do they compare? MakeMyTrip Ltd trades at $56.43 (market cap $5.05B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 14× MakeMyTrip Ltd's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| MMYT | REGN | |
|---|---|---|
Market Cap | $5.05B | $70.47B |
Sector | Technology | Health |
52-Week High | $103.21 | $812.27 |
52-Week Low | $36.30 | $545.46 |
Enterprise Value | $5.69B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
